How about Sanofi (Hangzhou) Pharmaceutical Co., Ltd.?

Introduction: Group Overview

Sanofi Group is the third largest pharmaceutical company in the world and the first in Europe. The group has a world-class R&D institution with approximately 11,000 scientists researching and developing innovative treatment solutions. Its main research areas include cardiovascular, thrombosis, tumors, central nervous system, diabetes, internal medicine and vaccines.

Sanofi Group is listed in Paris, France and New York, the United States.

The purpose of Sanofi Group is: Health

The Group’s Values

Innovation encourages forward thinking and we ignite creativity

Confidence is outstanding As a group, we are courageous and courageous

We respect each other and seek common ground while reserving differences. We respect each other

We work together to abide by social responsibilities and we have the courage to take responsibility

We act with integrity and self-denial and prudence and we stick to our promises

< p>The predecessor of Sanofi Hangzhou Factory, Hangzhou Sanofi Minsheng Pharmaceutical Co., Ltd. (a Sino-foreign joint venture), was registered and established in Hangzhou on November 30, 1995.

Sanofi’s Hangzhou factory is one of Sanofi’s six major production bases in China. It has more than 160 employees. The company produces and packages solid and oral preparations, and packaged injections. Its products cover internal medicine, central nervous system 21 prescription drugs and 4 OTC drugs in the fields of hypertension, cardiovascular, thrombosis and oncology.

In April 2009, Sanofi Group announced an investment of 429 million yuan to build a new production base in Hangzhou Binjiang High-tech Industrial Development Zone, and through upgrading and technological transformation of existing equipment, it has developed into Asia's largest pharmaceutical manufacturer. Export processing base.

The Hangzhou factory is currently located in the Binjiang new factory area.

Legal representative: Zhang Ping

Date of establishment: 1995-11-30

Registered capital: US$20 million

Region : Zhejiang Province

Unified Social Credit Code: 91330100609136127P

Business Status: Continuous

Industry: Manufacturing

Company Type: Limited Responsible company (foreign joint venture)

English name: Sanofi (Hangzhou) Pharmaceutical Co., Ltd.

Staff size: more than 1,000 people

Company address: Hangzhou No. 325 Jiangling Road, Binjiang District, City

Business scope: research, development, production: tablets, hard capsules, oral solutions, imported drug sub-packaging [tablets, powder for injection, freeze-dried powder for injection ( (containing anti-tumor drugs), small-volume injections (containing anti-tumor drugs)], psychotropic drugs (zolpidem tartrate tablets, zopiclone tablets), and related technical consultation, sales of self-produced products; wholesale and import of wet wipes and cosmetics Export, commission agent (except auction). (The import and export of the above commodities do not involve state-owned trade, import and export quota licenses, export quota bidding, export licenses and other specially managed commodities. Commodities involving other special regulations shall be handled in accordance with relevant national regulations). (Except for those involving the implementation of special access management measures stipulated by the state) (Projects that require approval according to law can only be launched after approval by relevant departments)